Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.75% |
| 2 | Healthcare | 9.01% |
| 3 | Technology | 7.75% |
| 4 | Financials | 7.01% |
| 5 | Consumer Discretionary | 6.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
CuriosityStream
CURI
$152M
| $1.9M | ﹤0.01% |
189,000
-61,000
| -24% | -$600K |
|
2527
WisdomTree India Earnings Fund ETF
EPI
$2.03B
| $1.9M | ﹤0.01% |
94,782
-75,735
| -44% | -$1.38M |
|
2528
Regis Corp
RGS
$67.5M
| $1.9M | ﹤0.01% |
11,588
+11,035
| +1,995% | +$2.07M |
|
2529
PUT
Corning
GLW
$132B
| $1.89M | ﹤0.01% |
73,100
-38,800
| -35% | -$880K |
|
2530
PolyPid
PYPD
$104M
| $1.89M | ﹤0.01% |
+3,500
| New | +$1.96M |
|
|
GAP
2531
PUT
The Gap Inc
GAP
$7.48B
| $1.89M | ﹤0.01% |
150,000
+105,000
| +233% | +$946K |
|
|
KAMN
2532
DELISTED
Kaman Corp
KAMN
| $1.89M | ﹤0.01% |
+45,493
| New | +$1.76M |
|
2533
Bio-Techne
TECH
$11.4B
| $1.89M | ﹤0.01% |
28,644
-5,860
| -17% | -$351K |
|
2534
Smith & Wesson
SWBI
$586M
| $1.89M | ﹤0.01% |
114,102
-522,823
| -82% | -$4.86M |
|
2535
Boston Omaha
BOC
$415M
| $1.88M | ﹤0.01% |
117,595
+97,878
| +496% | +$1.63M |
|
2536
Alamos Gold
AGI
$15.9B
| $1.88M | ﹤0.01% |
200,274
-985,440
| -83% | -$7.58M |
|
2537
PUT
Occidental Petroleum
OXY
$59.1B
| $1.88M | ﹤0.01% |
10,266
| – | – |
|
|
UBA
2538
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $1.87M | ﹤0.01% |
157,761
-47,208
| -23% | -$608K |
|
2539
HCA Healthcare
HCA
$90.8B
| $1.87M | ﹤0.01% |
19,253
-195,024
| -91% | -$20.3M |
|
2540
CGI
GIB
$15.4B
| $1.87M | ﹤0.01% |
29,635
-247,243
| -89% | -$15.4M |
|
2541
iShares Silver Trust
SLV
$33.8B
| $1.86M | ﹤0.01% |
+109,598
| New | +$1.67M |
|
|
HMHC
2542
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $1.86M | ﹤0.01% |
1,028,243
+324,472
| +46% | +$521K |
|
2543
CAE Inc
CAE
$8.01B
| $1.86M | ﹤0.01% |
114,846
+68,173
| +146% | +$1.05M |
|
|
HES
2544
DELISTED
Hess
HES
| $1.86M | ﹤0.01% |
35,870
-360,023
| -91% | -$16.5M |
|
|
AZUL
2545
DELISTED
Azul
AZUL
| $1.86M | ﹤0.01% |
166,088
+68,178
| +70% | +$656K |
|
2546
Utah Medical Products
UTMD
$229M
| $1.85M | ﹤0.01% |
+20,905
| New | +$1.88M |
|
2547
Enanta Pharmaceuticals
ENTA
$402M
| $1.85M | ﹤0.01% |
36,887
-43,296
| -54% | -$2.24M |
|
|
DMC
2548
Del Monte Corp
DMC
$1.48B
| $1.85M | ﹤0.01% |
+75,196
| New | +$1.97M |
|
2549
Regional Management Corp
RM
$301M
| $1.85M | ﹤0.01% |
104,492
-33,417
| -24% | -$522K |
|
2550
PUT
BioMarin Pharmaceuticals
BMRN
$12.6B
| $1.85M | ﹤0.01% |
+15,000
| New | +$1.49M |
|
Similar funds
Israel Englander's Q2 2020 Portfolio in Review
As of Q2 2020, Israel Englander held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $10.9B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 48% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Israel Englander's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Israel Englander added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Israel Englander's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Israel Englander fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Israel Englander's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Israel Englander opened 1,140 new positions and closed 798 in Q2 2020.
- Israel Englander's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.